From: The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus
Primate lentivirus | No. of genomes analysed | A (%) ± std | C (%) ± std | G (%) ± std | T (%) ± std |
---|---|---|---|---|---|
HIV-1, group M, subtype A | 3 | 35.1 ± 0.2 | 18.1 ± 0.2 | 24.4 ± 0.3 | 22.4 ± 0.4 |
HIV-1, group M, subtype B | 18 | 35.3 ± 0.2 | 18.1 ± 0.2 | 24.4 ± 0.2 | 22.3 ± 0.1 |
HIV-1, group M, subtype C | 18 | 35.5 ± 0.2 | 18.0 ± 0.2 | 24.2 ± 0.1 | 22.3 ± 0.1 |
HIV-1, group M. subtype D | 1 | 35.8 | 18.0 | 24.1 | 22.1 |
HIV-1, group O | 4 | 35.0 ± 0.2 | 19.0 ± 0.1 | 23.8 ± 0.2 | 22.2 ± 0.2 |
HIV-1, group N | 8 (gag-pol-env only) | 36.0 ± 0.2 | 17.6 ± 0.2 | 24.0 ± 0.1 | 22.2 ± 0.2 |
HIV-1, group P | 1 | 33.9 | 18.5 | 24.6 | 22.7 |
SIVchimpanzee | 7 | 35.3 ± 0.5 | 18.3 ± 0.2 | 23.8 ± 0.3 | 22.5 ± 0.2 |
SIVgorilla | 4 | 34.6 ± 0.0 | 18.5 ± 0.1 | 24.6 ± 0.1 | 22.3 ± 0.2 |
SIVmangabey | 3 | 34.0 ± 0.2 | 18.9 ± 0.2 | 25.1 ± 0.3 | 22.1 ± 0.4 |
SIVgreen monkey | 9 | 33.6 ± 0.6 | 19.3 ± 0.7 | 25.0 ± 0.5 | 22.0 ± 0.3 |
SIVmandrill | 3 | 34,6 ± 1.3 | 18.1 ± 1.8 | 24.5 ± 0.6 | 22.9 ± 1.1 |
HIV-2 | 16 | 33.9 ± 0.3 | 20.4 ± 0.5 | 24.9 ± 0.3 | 20.7 ± 0.5 |
pSIV (lemur endogenous lentivirus) | 1a | 29.0 | 20.5 | 27.5 | 23.1 |
Non-primate lentivirus | Â | Â | Â | Â | Â |
EAIV | 25 | 35.7 ± 0.2 | 16.0 ± 0.3 | 22.0 ± 0.2 | 26.4 ± 0.4 |
CAEV/Ovine lentivirusb | 7/4 | 38.0 ± 0.5 | 15.7 ± 0.6 | 25.2 ± 0.4 | 21.1 ± 0.4 |
CAEV subtype E | 2 | 33.9 ± 0.3 | 28.1 ± 0.0 | 28.1 ± 0.2 | 19.5 ± 0.0 |
Maedi-visna virus | 6 | 37.2 ± 0.2 | 26.0 ± 0.1 | 26.0 ± 0.1 | 21.4 ± 0.0 |
Jembrana disease virus | 1 | 31.7 | 20.1 | 26.4 | 21.9 |
BIV | 1 | 31.8 | 21.2 | 23.8 | 23.2 |
FIV cat/cougar | 4/14 | 38.0 ± 0.3 | 14.9 ± 0.1 | 22.0 ± 0.3 | 25.2 ± 0.3 |
FIV Pallas’ cat/lionc | 1/2 | 38.0 ± 0.1 | 13.7 ± 0.3 | 22.1 ± 0.3 | 26.2 ± 0.6 |
RELIK (hare endogenous lentivirus)d | 1 (gag-pol-env only) | 34.0 | 19.4 | 22.4 | 24.1 |
ELVmpf (ferret endogenous lentivirus) | 1 | 33.6 | 20.0 | 23.6 | 22.8 |